After miR-29 inhibition, the PI3K/mTOR/HIF-1α/VEGF pathway was activated, and VEGF expression was increased, thereby promoting angiogenesis, protecting the myocardium, and improving MI, which were verified by in-vivo and in-vitro experiments (Figures 6, 7). This evidence concerns the gene MTOR and myocardial infarction.